ArticleClinical, cosmetic and investigational dermatology2025
Impact of Rosacea on the Quality of Life: A Population-Based Cross-Sectional Study in Saudi Arabia.
Article in Clinical, cosmetic and investigational dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Neurohormonal-Immune Dysregulation in Rosacea: Emerging Perspectives from the Skin-Gut-Brain Axis.Drug design, development and therapy · 2026Review
- Depression and Anxiety in Patients with Rosacea and Their Impact on Quality of Life: A Cross-Sectional Study.Clinical, cosmetic and investigational dermatology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Rosacea is a chronic skin condition that affects social and professional life, with a prevalence of 1.59%in Saudi Arabia. It has four subtypes and is linked to anxiety, depression, and reduced quality of life (QoL). Many patients report diminished self-esteem and social challenges. Given the limited research in Saudi Arabia, this study aims to assess rosacea's impact on QoL. Patients and Methods: This cross-sectional study was conducted at a single secondary institution and via social media outreach to Saudi residents with a confirmed diagnosis of rosacea. Participants completed an electronic questionnaire covering sociodemographic data, rosacea severity, and Dermatology Life Quality Index (DLQI) scores. The data were analyzed using descriptive statistics, Results: A total of 176 patients were included in the study, with a mean age of 28.8 years. More than half of the participants (52.5%) reported that rosacea had severely impaired their quality of life. Increased disease severity, as indicated by higher Clinician's Erythema Assessment (CEA) scores, the presence of papules, and ocular involvement, was significantly associated with poorer QoL. A longer duration of disease was positively correlated with greater QoL impairment. There was a higher prevalence of topical ivermectin use among individuals reporting severe impairment in quality of life. Conclusion: This study underscores the substantial impact of rosacea on patients' quality of life in Saudi Arabia, particularly in emotional and social domains. Higher DLQI scores were significantly associated with longer disease duration and greater clinical severity. As a result of these findings, it is imperative to treat rosacea holistically, addressing both its physical manifestations and psychological burden of rosacea.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.